Sartorius Stedim Biotech Launches Service for Characterization of New Biological Entities

Germany: Testing for Innovator Molecules Sartorius Stedim Biotech Launches Service for Characterization of New Biological Entities

27.01.2019Editor: Alexander Stark

Sartorius Stedim Biotech (SSB) announced the launch of services for new biological entities, called NBE Product Characterization. The company provides a comprehensive range of testing for innovator molecules available either as off-the-shelf assays or custom assay development for more complex proteins.

Sartorius Stedim Bio Outsource’s testing services are fully customizable for clients to ensure their innovator drugs are tested based on the right regulatory requirements.
(Source: Sartorius AG)

Goettingen/Germany; Glasgow/UK — These services are offered by its subsidiary, Sartorius Stedim Bio Outsource based in Glasgow, UK, and in Cambridge, Massachusetts, USA. The tests offered by the company include cell-based potency assays, bioassays and binding assays, as well as physicochemical and structural analyses, enabling customers to benefit from a fully integrated package. These testing services are fully customizable for clients to ensure their innovator drugs are tested based on the right regulatory requirements by expert scientists, the supplier announced. Robust data packages proving the safety, purity and potency as required by the regulatory authorities smooth the submissions process for approval by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA).

Sartorius Stedim Biotec’s new bioreactor is designed for scale-out expansion of cells including patient-specific T cells and is a closed system.

As a result of these fully customizable methods and data packages available for monoclonal antibody characterization that complement Bio Outsource’s and Sartorius Stedim Cellca’s existing innovative offer for biologics, pharmaceutical companies could work with one contract partner from cell line development to qualification and validation of analytical and biological product characterization assays. A panel of assays suitable for mAb characterization is to allow drug developers to fast-track complex bioassay development using the supplier's platform methods.

Gallery

Unfold for details of your consent

Stand vom 23.03.2021

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.

(ID:45709925)

Germany: Testing for Innovator Molecules Sartorius Stedim Biotech Launches Service for Characterization of New Biological Entities

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Consent to the use of data for promotional purposes